Schedule 13G ownership disclosure
Halozyme Therapeutics Inc
Security class unavailable · CUSIP: 40637H109
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 13,542,589
- Percent of class
- 10.0200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-126222
- Form type
- SC 13G
- Filer
- HALOZYME THERAPEUTICS, INC.
- CIK
- CIK 1159036
- Filed
- Dec 12, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership